Edwards Lifesciences (EW) Reports Mixed Q3 Results; Guides Q4, Revises FY10 Outlook

October 25, 2010 3:59 PM

Edwards Lifesciences (NYSE: EW) reports Q3 non-GAAP EPS of $0.43, 1c better than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found